ADVFN - Advanced Financial Network.
HOME» NASDAQ » M » MYL Stock Price » MYL Stock News

Mylan Inc. Share News

 Mylan Inc. (mm) Stock Price
MYL Stock Price
 Mylan Inc. (mm) Stock Chart
MYL Stock Chart
 Mylan Inc. (mm) Stock News
MYL Stock News
 Mylan Inc. (mm) Company Information
MYL Company Information
 Mylan Inc. (mm) Stock Trades
MYL Stock Trades

Mylan Confirms Endo Suit Over Generic Migraine Drug Application

DOW JONES NEWSWIRES Mylan Inc. (MYL) confirmed Wednesday that it has been sued by Endo Pharmaceuticals Holdings Inc. (ENDP) over its application for approval of a generic drug used to treat acute migraine headaches in adults. Mylan--one of the world's largest generic drug makers--said it believes it is the first company to file a substantially complete application for approval of frovatriptan succinate EQ, a generic version of Frova. The company said it expects to qualify for 180 days of marketing exclusivity upon final approval from the Food and Drug Administration. Mylan, which has had litigation-related charges figure prominently in its recent quarterly results, last month reported second-quarter earnings surged 70% as sales got a lift from a weaker dollar. Shares closed Tuesday at $20.01 and were inactive in recent premarket trade. Through the latest close, the stock is down 5.3% since the start of the year. -By Mia Lamar, Dow Jones Newswires; 212-416-3207; mia.lamar@dowjones.com

Stock News for Mylan Inc. (MYL)
DateTimeHeadline
04/29/201618:53:25Amended Annual Report (10-k/a)
04/29/201614:32:16Statement of Changes in Beneficial Ownership (4)
04/19/201608:00:00Mylan to Report First Quarter 2016 Financial Results on May 3...
04/14/201610:34:53Filing of Certain Prospectuses and Communications in Connection...
04/14/201610:33:56Current Report Filing (8-k)
04/11/201617:24:18Securities Registration: Business Combination (s-4)
04/11/201607:00:00Mylan Launches First and Only Available Intermediate Dosage Strengths...
04/06/201611:14:00Mylan Launches Generic Epivir® Tablets
04/04/201617:33:26Statement of Changes in Beneficial Ownership (4)
03/30/201617:52:26Filing of Certain Prospectuses and Communications in Connection...
03/28/201619:01:31Statement of Changes in Beneficial Ownership (4)
03/28/201613:31:00Mylan Launches Generic Ultram® Extended-Release Tablets
03/18/201614:08:06Statement of Changes in Beneficial Ownership (4)
03/15/201617:25:01Filing of Certain Prospectuses and Communications in Connection...
03/11/201610:02:04Current Report Filing (8-k)
03/11/201609:59:49Filing of Certain Prospectuses and Communications in Connection...
03/09/201609:03:52Filing of Certain Prospectuses and Communications in Connection...
03/09/201608:57:06Current Report Filing (8-k)
03/04/201610:30:00Mylan to Present at the Barclays Global Healthcare Conference
03/04/201610:00:00Mylan to Present at the Raymond James 37th Annual Institutional...

Mylan Inc. and other NASDAQ stock quotes are delayed by at least 20 minutes.
All other stock price and quote data is delayed by at least 15 minutes unless otherwise stated. By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Contact Us | Copyright 1999-2015 ADVFN PLC. | Privacy Policy | Investment Warning | Data accreditations | Investor Relations

ADVFNADVFN ItalyADVFN GermanyADVFN FranceADVFN BrazilADVFN JapanADVFN UKADVFN US noad